Home

CRAIG R SMITH

CIK 938742 · last filed 2020-03-16

CRAIG R SMITH is a corporate insider who has filed 33 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider bought $102.0K of ADX on Mar 16, 2020. Across all open-market trades the lifetime net is +$94.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.63M

Companies

4

Total Filings

33

Lifetime Open-Market Net

$94.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ADX Director 54,469 $25.98 $1.42M $231.7K 12 2020-03-16
PEO Director 7,812 $27.45 $214.4K -$135.5K 2 2018-05-31
Assertio Therapeutics, Inc (DEPO) Delisted Director — — — $0 6 2012-12-06
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Director 0 $6.22 $0 -$1.5K 4 2009-02-27

Recent Filings

33 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-03-16 ADX Buy (P) +8,000 $102.0K EDGAR
2019-04-23 ADX Buy (P) +17,000 $253.6K EDGAR
2018-06-01 ADX Mixed −6,621 -$101.0K EDGAR
2018-05-31 PEO Mixed −1,331 -$27.2K EDGAR
2018-05-31 ADX Mixed −6,621 -$101.0K EDGAR
2015-12-16 PEO Sell (S) −6,100 -$108.3K EDGAR
2013-03-21 ADX Grant (A) +750 $8.8K EDGAR
2013-03-21 — Grant (A) +400 $10.3K
2012-12-06 Assertio Therapeutics, Inc (DEPO) Delisted Grant (A) — $0 EDGAR
2012-03-21 ADX Grant (A) +750 $0 EDGAR
Showing 1–10 of 33
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.